Does cancer that occurs during or after anti–tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents

✍ Scribed by Pauline Raaschou; Julia F. Simard; Martin Neovius; Johan Askling; Anti-Rheumatic Therapy in Sweden Study Group

• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 149 KB
• Volume: 63
• Category: Article
• ISSN: 0004-3591
• DOI: 10.1002/art.30247